In CAD patients cardiomyocytes release products of oxidation that likely activate PPARγ-dependent upregulation of adiponectin expression in EAT, which can act as a defense mechanism (Antonopoulos et al., 2016). This evidence concerns the gene ADIPOQ and coronary artery disorder.